Novo Nordisk Enters Its First Strategic RNAi Pact
Alliance With Dicerna To Explore More Than 30 targets
Novo Nordisk’s head of global drug discovery tells Scrip he hopes the strategic collaboration with Dicerna Pharmaceuticals will generate clinical candidates within three years.
